Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist, nilvadipine

T. Tsuchihashi, A. Tsukashima, K. Matsumura, I. Abe, M. Tominaga, Y. Nakao, K. Kobayashi, M. Fujishima

研究成果: Contribution to journalArticle査読

4 被引用数 (Scopus)

抄録

A newly developed calcium antagonist, nilvadipine, was administered to 7 hypertensive patients aged 75.6 y. Nilvadipine 4 mg b.d. decreased the average 24-h blood pressure significantly from 169/89 mm Hg to 152/81 mm Hg after 7 to 14 days without any change in the pulse rate. The circadian patterns of blood pressure and pulse rate were not affected by nilvadipine. Although the present study was a preliminary one done over a short period in a small number of patients, the results suggest that nilvadipine exerts an antihypertensive effect without altering the circadian pattern or the variability of blood pressure in elderly hypertensive patients.

本文言語英語
ページ(範囲)255-257
ページ数3
ジャーナルEuropean Journal of Clinical Pharmacology
41
3
DOI
出版ステータス出版済み - 9 1 1991

All Science Journal Classification (ASJC) codes

  • 薬理学
  • 薬理学(医学)

フィンガープリント

「Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist, nilvadipine」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル